Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men

JAMA

Volumn 280, Issue 1, 1998, Pages 61-66

  Schacker, Timothy ^a,d   Ryncarz, Alexander J ^b,c   Goddard, James ^b   Diem, Kurt ^b   Shaughnessy, Mary ^b   Corey, Lawrence ^a,b,c,e  

^a Departments of Laboratory Medicine   (United States)

^b Laboratory Medicine   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MALE; PRIORITY JOURNAL; RNA ANALYSIS; SEXUAL TRANSMISSION; VIRUS DETECTION; VIRUS TRANSMISSION;

EID: 0032122348     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.1.61     Document Type: Article

References (42)

1. Ryder RW, Ndilu M, Hassig SE, et al. Heterosexual transmission of HIV-1 among employees and their spouses at two large businesses in Zaire. AIDS. 1990;4:725-732.
2. Otten MW Jr, Zaidi AA, Peterman TA, Rolfs RT, Witte JJ. High rate of HIV seroconversion among patients attending urban sexually transmitted disease clinics. AIDS. 1994;8:549-553.
3. Castro KG, Lieb S, Jaffe HW, et al. Transmission of HIV in Belle Glade, Florida: lessons for other communities in the United States. Science. 1988; 238:193-197.
4. Clumeck N, Taelman H, Hermans P, Piot P, Schoumacher M, DeWit S. A cluster of HIV infection among heterosexual people without apparent risk factors. N Engl J Med. 1986;321:1460-1462.
5. European Study Group. Risk factors for male to female transmission of HIV. BMJ. 1989;298:411-415.
6. Cameron DW, Simonson JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 1989;2:403-407.
7. Latif AS, Katzenstein DA, Basset MT, Houston S, Emmanual JG, Marowa E. Genital ulcers and transmission of HIV among couples in Zimbabwe. AIDS. 1989;8:519-523.
8. Piot P, Plummer FA. Genital ulcer adenopathy syndrome. In: Holmes KK, ed. Sexually Transmitted Diseases. 2nd ed. New York, NY: McGraw Hill; 1989:711-716.
9. Augenbraun MH, McCormack WM. Sexually transmitted diseases in HIV-infected persons. Infect Dis Clin North Am. 1994;8:439-448.
10. Corey L, Holmes KK. Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med. 1983;98: 973-983.
11. O'Farrell N, Tovey SJ. High cumulative incidence of genital herpes amongst HIV-1 seropositive heterosexuals in south London. Int J STD AIDS. 1994;5:415-418.
12. Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med. 1995;123:845-847.
13. Schacker T, Hu HL, Koelle DM, et al. A double blind, placebo-controlled trial of famciclovir for suppression of symptomatic and asymptomatic HSV reactivation in HIV-infected persons. Ann Intern Med. 1998;128:21-28.
14. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest. 1997;99:1092-1097.
15. Koutsky LA, Stevens CE, Holmes KK, et al. Under diagnosis of genital herpes by current clinical and viral isolation procedures. N Engl J Med. 1992; 326:1533-1539.
16. Wald A, Benedetti J, Davis G, Remington M, Winter C, Corey L. A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections. Antimicrob Agents Chemother. 1994;38:174-176.
17. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med. 1995;333:770-775
18. Langenberg A, Zbanyszek R, Dragavon J, Ashley R, Corey L. Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus. J Clin Microbiol. 1988;26: 1772-1774.
19. Kreiss JK, Coombs RW, Plummer F, et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis. 1989; 160:380-384.
20. Cone RW, Hobson AC, Palmer J, Remington M, Corey L. Extended duration of herpes simplex virus DNA in genital lesions detected by polymerase chain reaction. J Infect Dis. 1991;164:757-760.
21. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med. 1995; 122:573-579.
22. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med. 1996;334:426-431.
23. Piatak M Jr, Yang LC, Luk KC, et al. Viral dynamics in primary HIV-1 infection. Lancet. 1993; 341:1099.
24. Delwart EL, Shpaer EG, Louwagie J, McCutchan FE. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science. 1993;262:1257-1261.
25. Delwart EL, Sheppard HW, Walker BD, Goudsmit J. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol. 1994;68:6672-6683.
26. Delwart EL, Busch MP, Kalish ML, Mosley JW, Mullins JI. Rapid molecular epidemiology of human immunodeficiency virus transmission. AIDS Res Hum Retroviruses. 1995;11:1081-1093.
27. Delwart EL, Herring B, Rodrigo AG, Mullins JI. Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay. PCA Meth Application. 1995;4:S202-S216.
28. Peterman TA, Stoneburner RL, Allen JR, Jaffee HW, Curran JW. Risk of HIV virus transmission from heterosexual adults with transfusion associated infections. JAMA. 1988;259:55-58.
29. Stanley S, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med. 1996;334:1222-1230.
30. O'Brien WA. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood. 1995;86:1082-1089.
31. Rios Z, Rios EO, Garcia MI, et al. Changes in viral expression and cytokine profile induced by a polyantigenic immunomodulator in HIV-infected peripheral blood mononuclear cells. Cell Molec Biol. 1995;41:S93-S101.
32. Brichacek B, Swindells S, Janoff EN, Pirruccello S, Stevenson M. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis. 1996;174:1191-1199.
33. Cunningham A, Turner RR, Miller AC, Para MF, Merigan TC. Evolution of recurrent herpes simplex lesions: an immunohistologic study. J Clin Invest. 1985;75:226-233.
34. Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L. Direct recovery of HSV-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J Infect Dis. 1994;169:956-961.
35. Fauci AS. The human immunodeficiency virus infection and mechanism of pathogenesis. Science. 1988;239:617-622.
36. Golden MP, Kim S, Hammer SM, et al. Activation of human immunodeficiency virus by herpes simplex. J Infect Dis. 1992;166:494-499.
37. Albrecht MA, DeLuca NA, Byrn RA, Schaffer PA, Hammer SM. The herpes simplex virus immediate-early protein, ICP4 is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes. J Virol. 1989;63:1861-1868.
38. Ostrove JM, Leonard J, Week KE, Rabson AB, Gendelman E. Activation of human immunodeficiency virus by herpes simplex type 1. J Virol. 1987;61: 3726-3732.
39. Mosca JD, Bednarik DP, Yaj NBK, et al. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that response to a trans-acting factor encoded by herpes simplex virus 1. Proc Natl Acad Sci USA. 1987;84:7408-4712.
40. Margolis DM, Rabson AB, Straus SE, Ostrove JM. Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes. Virology. 1992;186:788-791.
41. Kucera LS, Leake E, Iyer N, Raben D, Myrvik QN. Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfeet and simultaneously replicate in the same human CD4+ cell: effect of coinfection on infectious HSV-2 and HIV-1 replication. AIDS Res Hum Retroviruses. 1990;6:641-647.
42. Heng MC, Heng SY, Allen SG. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet. 1994;343:255-258.